September 3, 2021
On September 1st, Inflectra hosted a webinar called Spira v6.11 - New Features and Enhancements. Adam Sandman, Inflectra's Director of Technology, covered the following topics in the live webinar:
Multi-factor authentication
New diagram, flowchart, and organization chart editor
Agile planning board & task tracking enhancements
If you missed the webinar, we have a full recap below.
Read MoreJanuary 28, 2021
We're very excited about the upcoming release of SpiraPlan 6.7.1 for both our cloud and on-premise customers. In addition to the powerful new tools for developers and DevOps engineers, we also have some new document management enhancements that will be amazing for customers working in the life sciences, especially on GxP projects that have to follow FDA / EMA rules such as 21 CFR Part 11.
Read MoreMay 17, 2018
Thanks to those who attended our recent webinar discussing the challenges and opportunities testing and validating software and systems in the life sciences and healthcare industries. We have published a recording of the webinar and Q&A.
Read MoreMarch 12, 2018
In this presentation we discuss some of the unique testing and compliance requirements for IT projects in healthcare and the life sciences. We discuss the move to the cloud, the opportunities and challenges it will bring, and how the Inflectra platform can help. We then have a practical demonstration of our two products - SpiraTeam and Rapise - that can help you achieve compliance faster and more affordably than ever before.
Read MoreDecember 7, 2017
At Inflectra we like to make the lives of customers easier and share knowledge. We have lots of customer in the life sciences industries using SpiraTeam to manage and test medical device systems and products. Since such products have to follow the FDA 21 CFR Part 11 requirements, we thought it would be useful to highlight some of the best practices we have for configuring SpiraTeam in such environments. This is the fourth article in the blog series, and covers the configuration of the release workflows.
Read MoreDecember 5, 2017
At Inflectra we like to make the lives of customers easier and share knowledge. We have lots of customer in the life sciences industries using SpiraTeam to manage and test medical device systems and products. Since such products have to follow the FDA 21 CFR Part 11 requirements, we thought it would be useful to highlight some of the best practices we have for configuring SpiraTeam in such environments. This is the third article in the blog series, and covers the configuration of the test case workflows.
Read MoreNovember 29, 2017
At Inflectra we like to make the lives of customers easier and share knowledge. We have lots of customers in the life sciences industries using SpiraTeam to manage and test medical device systems and products. Since such products have to follow the FDA 21 CFR Part 11 requirements, we thought it would be useful to highlight some of the best practices we have for configuring SpiraTeam in such environments. This is the second article in the blog series, and covers the configuration of the requirements workflows.
Read MoreNovember 20, 2017
At Inflectra we like to make the lives of customers easier and share knowledge. We have lots of customer in the life sciences industries using SpiraTeam to manage and test medical device systems and products. Since such products have to follow the FDA 21 CFR Part 11 requirements, we thought it would be useful to highlight some of the best practices we have for configuring SpiraTeam in such environments.
Read MoreApril 29, 2016
In this morning's Washington Post, there was an article about 'The new sheriff in town' describing how the new biotechnology and drug screening startups in Silicon Valley are colliding with the conservative, formal testing philosophy of the United States Food & Drug Administration (FDA).
September 18, 2015
When developing software, systems and hardware for use in medical devices, healthcare IT systems or pharmaceutical processes, you need to follow a requirements and quality management process that complies with the FDA Title 21 CFR Part 11 set of Federal Regulations. Part 11 (as it's more commonly called) defines the criteria under which electronic records and electronic
signatures are considered trustworthy, reliable, and equivalent to paper
records.